for those MMA III concentrations that also induced TNF-α over-expression. Other effects of MMA III on cortical astrocytes included increased proliferative and metabolic activity. All tested MMA III concentrations led to an inhibition of intracellular lactate dehydrogenase (LDH) activity. Results suggest that MMA III induces important metabolic and functional changes in astrocytes that may affect brain homeostasis and that inflammation may play a major role in cognitive impairment-related pathogenicity in Asexposed populations.
Introduction
Arsenic is a highly toxic metalloid widespread in nature and may occur as trivalent arsenite (As 3+ ) or pentavalent arsenate (As 5+ ). Inorganic compounds of As (iAs) are commonly present in underground water and, therefore, iAs-containing drinking water is the main human exposure source. Hydroarsenicism is a common health problem that threatens the health of millions of people around the world (IARC 2012). Once iAs enters cells, it gets conjugated with glutathione and methylated by As III -methyl transferase (As3MT) in two consecutive stages, generating the highly toxic monomethylated (MMA III or V ) and dimethylated (DMA III or V ) metabolites [1] . iAs and its metabolites are eliminated through urine and feces, but an important proportion of them will accumulate in different tissues, including the brain [2] . iAs and its metabolites accumulate in the cerebral cortex, hippocampus, striatum, midbrain, thalamus, pons, medulla oblongata, and pituitary gland of rodents intoxicated with 2.5, 5, and 10 mg/kg/day of sodium arsenite [3, 4] .
Abstract Long-term exposure to inorganic arsenic (iAs) through drinking water has been associated with cognitive impairment in children and adults; however, the related pathogenic mechanisms have not been completely described. Increased or chronic inflammation in the brain is linked to impaired cognition and neurodegeneration; iAs induces strong inflammatory responses in several cells, but this effect has been poorly evaluated in central nervous system (CNS) cells. Because astrocytes are the most abundant cells in the CNS and play a critical role in brain homeostasis, including regulation of the inflammatory response, any functional impairment in them can be deleterious for the brain. We propose that iAs could induce cognitive impairment through inflammatory response activation in astrocytes. In the present work, rat cortical astrocytes were acutely exposed in vitro to the monomethylated metabolite of iAs (MMA III ), which accumulates in glial cells without compromising cell viability. MMA III LD 50 in astrocytes was 10.52 μM, however, exposure to sub-toxic MMA III concentrations (50-1000 nM) significantly increased IL-1β, IL-6, TNF-α, COX-2, and MIF-1 gene expression. These effects were consistent with amyloid precursor protein (APP) and β-secretase (BACE-1) increased gene expression, mainly inflammatory response, releasing and responding to a variety of immune mediators including pro-(IL-6, TNF-α and GM-CSF) and anti-inflammatory (IFN-β and TGFβ) cytokines, and chemokines (CCL2, CCL5) [19] .
One of the most characteristic pathologic features of neurodegenerative diseases and advanced cognitive deficits is the insoluble extracellular deposits of amyloid plaques, which are mainly composed of β-amyloid fibrils [20, 21] . Neurons are known to be major sources of Aβ in the brain, however, astrocytes exceed several times the number of neurons and recent reports suggest that astrocytes produce and accumulate Aβ and over-express the amyloid precursor protein (APP) cleaving enzyme, β-secretase (BACE-1) in response to chronic stress, promoting the pro-amyloidogenic pathway. Thus, even a small level of astrocytic Aβ production could make a significant contribution to Aβ production in neurological and neurodegenerative diseases. Moreover, activated astrocytes may increase Aβ generation in neurons due to the release of inflammatory mediators [22, 23] .
Based on these observations, our group proposes that Asinduced neurotoxicity could involve its ability to activate oxidative and inflammatory responses in astrocytes and, in this way, could contribute to the pathophysiology of Asrelated cognitive deficit in As-exposed populations.
The aim of this study was to evaluate oxidative and inflammatory responses in rat cortical astrocytes acutely exposed to the monomethylated metabolite of As, MMA III , and to determine its association with cells activation and the expression of APP and BACE-1, whose increased expression is usually associated with cognitive impairment and neurodegeneration.
Methods

Reagents
Monomethylarsonous acid (MMA III ) was synthetized at the University of Arizona. Dulbecco's modified Eagle's medium (DMEM), phenol red-free DMEM, fetal bovine serum (F BS), and penicillin/streptomycin solution were obtained from GIBCO/Invitrogen. CellTiter 96 ® Aqueous Non-Radioactive Cell Proliferation Assay was purchased from PRO-MEGA (F itchburg, WI, USA). Cytotoxicity detection kit lactate dehydrogenase (LDH) was obtained from ROCHE (Indianapolis, IN, USA). Reagents for nitrite assay (Griess reaction), LPS (from Escheri chi a coli ), and poly-d-lysine were purchased from Sigma Chemical Co. (St. Louis, MO).
Astrocyte Primary Cultures
Primary cortical astrocyte cultures were obtained through a modified method previously described [24] . All procedures Although several observations point out that human exposure to iAs may be associated with neurodegenerative diseases, epidemiological studies have failed to demonstrate a significant association. However, stronger evidence from exposed populations and experimental studies have linked iAs exposure with cognitive impairment [5] [6] [7] [8] . In exposed populations, a decreased verbal IQ in a dose-response manner has been reported in children with high urinary As concentration [9] , and cognitive impairment was also found in a study conducted with children exposed to low iAs levels [10, 11] . In adult populations, a significant correlation between exposure to As and an impaired cognitive ability even at As concentrations below the EPA standards (10 μg/L) for drinking water has been reported also [12] . Even though these studies in exposed populations have some design limitations, results have contributed to propose that chronic exposure to iAs, at concentrations considered to be safe by the EPA and WHO, leads to cognitive impairment in exposed populations and could contribute to increase the risk for neurodegenerative diseases development later in life.
Studies evaluating hippocampal-dependent tasks in rodents have supported such observations. F or example, in utero and early life exposure of rodents even to 50 or 100 μg/μL of iAs through drinking water leads to learning and memory deficits in adult offspring [3, 13] . In another study, perinatal mice exposure to low iAs concentration (55 μg/L) led to reduced performance in forced swim test and increased response time in learned helplessness [10] . However the mechanisms underlying such neurotoxic effects that lead to As-associated cognitive dysfunction have not been completely elucidated.
In the clinical literature, It has been recognized that healthy individuals very often develop an important cognitive decline following an inflammatory challenge, such as an infection, surgery or head injury [14] . These observations suggest that any pro-inflammatory stimulus or agent that gains entry to the body through different routes could induce the same negative effect on human cognitive functions. In this sense, several reports have shown that acute or chronic exposure to iAs or its methylated metabolites lead to inflammatory responses activation in diverse cell types [15] [16] [17] ; therefore, exposure to arsenicals may increase the risk for cognitive impairment through the induction of a sustained inflammatory response.
Although microglial cells, the resident macrophages in brain, have been extensively studied as main effectors of neuroinflammation-associated neurodegeneration, the role of astrocytes as contributors to cognitive impairment and neurodegenerative diseases pathophysiology is currently well recognized, because astrocytes, the most abundant glial cells, play an important role in maintaining the central nervous system's (CNS) physiology [18] . Additionally, astrocytes have been shown to be key regulators of the brain bovine serum and 100 U/mL penicillin and 100 μg/mL streptomycin. Cytotoxicity was estimated using a commercial system (Cytotox 96 ® nonradioactive cytotoxicity assay, PROMEGA), which determines LDH enzyme activity, according to the provider's guidelines. This is a colorimetric assay that measures the enzymatic conversion of lactate to pyruvate exerted by LDH, which is released to the medium from damaged cells. The enzymatic activity in culture supernatants is determined by the NADH-mediated conversion of a tetrazolium salt into a red formazan product. The color intensity is proportional to the number of lysed cells and can be determined spectrophotometrically, recording absorbance (Abs) at 490 nm. Supernatants from lysed cells obtained by the use of a lysis buffer provided by the manufacturer were used as positive control (100 % of LDH activity or cellular toxicity). Cellular toxicity was calculated as a percentage of control (percent cytotoxicity = 100 × [experimental LDH release (OD490)/maximum LDH release (OD490)]). LD 50 was calculated from these data using linear regression. In this work, results are presented as cellular viability, which was determined by subtracting cellular toxicity data from non-exposed cells data, which were considered to be as 100 % viability.
In a different group of experiments, cells were incubated with 25-5000 nM MMA III for 24 or 48 h. In one set of cultures, the medium was removed and cells were lysed after 24 or 48 h exposure with the lysis buffer provided by the assay kit's manufacturer. In another set of cellular cultures, supernatants were recovered after 24 or 48 h exposure. LDH activity was measured in supernatants and in cellular lysates, as described before. Cells without exposure to MMA III were included as control. These results are presented as LDH activity as a function of the MMA III concentration to which the astrocytes were exposed.
Morphological Changes
To determine whether MMA III induces morphological changes associated with astrocytes activation due oxidative or inflammatory responses, 1.5 × 10 4 cells/well were seeded in 12 well-flat-bottom culture plates; 24 h later, the medium was replaced by fresh supplemented DMEM medium containing 50, 250, 500, 1000 nM MMA III . Morphological changes were recorded in each well after 24 and 48 h with the use of a Nikon ECLIPSE TS100 inverted phase-contrast microscope; images were taken and processed with the use of the Q Capture Pro-7 digital camera system. Each MMA III concentration was evaluated for morphological changes induction in triplicate and at least three different images per well were taken.
ROS Production
Arsenic has been well demonstrated to induce oxidative stress, as its main toxicity mechanism. Reactive described in this manuscript were carried out in accordance to the Guide for the Care , the cortices were then peeled and the hippocampus and meninges from each individual cortex were carefully removed and discarded. The cleaned cortices were mechanically dissociated by sequential passage through a 1 mL pipette, 5 and 1 mL syringes, respectively, the sediment was suspended and cultured in 75 cm 2 tissue culture flasks pre-coated with poly-d-lysine with DMEM containing 10 % fetal bovine serum and 100 U/mL penicillin and 100 μg/mL streptomycin. The cultures were maintained at 37 °C with 5 % CO 2 in a 100 % humidified atmosphere. The medium was changed every 3 days. When cells grew to confluence (approximately 7-10 days), flasks were shaken overnight (170 rpm at 37 °C) to get rid of microglia and oligodendrocytes. After shaking, the medium was removed and the astrocytes were washed three times with ice-cold PBS solution and lifted by trypsinization and re-plated at different densities depending on the experiment to be performed. The purity of the primary culture of astrocytes was determined by immunocytochemistry with antibodies against glial fibrillary acidic protein (GFAP). A >95 % purity was considered adequate.
GFAP-Immunofluorescence Staining
Immunostaining for GF AP was used for astrocytes culture characterization. Cells were cultured in PDL-treated 12-mm glass cover-slips placed at the bottom of a 12-well plate (3 × 10 4 cells/well) and left to attach for 3 h; 1 mL of complete DMEM was added to each well and incubated overnight. Cells were then washed with PBS, fixed in 4 % paraformaldehyde for 20 min, permeabilized with methanol at −20 °C for 10 min, and pre-incubated with 2 % bovine albumin in PBS for 1 h. F ixed cells were incubated overnight at 4 °C with the primary antibody (rabbit anti-GFAP, 1:200 dilution, Sigma Chemical Co.) followed by a 1 h incubation with Alexa 488-conjugated goat anti-rabbit secondary antibody, 1:200 dilution (Molecular Probes, Eugene, OR, USA). The cell nucleus was counter-stained with 4′6,-diamidino-2-phenylindole dihydrochloride (DAPI) and observed with a fluorescence microscope.
Cytotoxicity Assay, LD 50
To determine lethal MMA III concentrations, toxicity assays and LD 50 were conducted in primary cortical astrocytes. Astrocytes, 8 × 10 3 cells/well, were treated with 0, 50, 125, 250, 500, 1250, 2500, 5000, 10,000, and 15,000 nM MMA III , for 24 and 48 h in phenol red-free DMEM containing 2 % fetal cycles. Immune complexes were detected by means of TMB substrate for 15 min and quantified by measuring the absorbance at 450 and 690 nm. Proliferation assay was conducted in duplicate with triplicates of each condition.
MTS-Based Metabolic Assay
Astrocytes were seeded in 96-well, flat-bottom, plates at a density of 8 × 103 cells/well for 24 h, then, exposed to 0, 50, 250, 500 and 1000 nM MMA III and allowed to grow for 24 additional hours. F ollowing the arsenic treatment, cells metabolic activity was measured using the MTSbased CellTiter 96-cell assay (PROMEGA), according to manufacturer's recommendations.
-tetrazolium] reduction technique evaluates intracellular NADH-dependent dehydrogenase activity in viable cells.
Cytokines, APP and BACE-1 Gene Expression Assays
After isolation from rats brain cortex, cortical astrocytes were cultured in 75 mm Petri dishes, left to settle for 24 h in supplemented DMEM, and then exposed to 25, 50, 125, 250, 500 and 1000 nM MMA III in triplicate for 6 h. Total RNA was isolated from each plate using the Trizol ® reagent (Invitrogen, Life Technologies, Waltham, MA, USA) according to the manufacturer's protocol. cDNA synthesis was performed using SuperScript II Reverse Transcriptase (Invitrogen, Life Technologies), following the manufacturer's recommendations. Real time PCR was carried out in 96-well reaction plates using the super Syber mix (ROCHE) with specific primers in a 10-µL final volume reaction. The PCR was conducted in an ABI 7500 detection system (Applied Biosystems, F oster City, CA, USA) with the following cycling conditions: 95 °C for 10 min (initial denaturation), 40 cycles of 95 °C for 15 s, and 60 °C for 60 s for annealing and extension. Amplification of the target cDNA was normalized to β-actin expression. Relative mRNA expression levels of each gene were calculated using the 2 −∆∆CT method. Primers for interleukin 1-beta (IL-1β), interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α), macrophage inhibitory factor (MIF), cyclooxigenase 2 (COX2), amyloid precursor protein (APP), and BACE-1 are listed in Table 1 .
Statistical Analysis
At least three independent experiments using primary astrocyte cultures pooled from one to three cortices for each experiment were analyzed. Statistical significance was determined by one or two-way ANOVA with Newman-Keuls or Tukey post-test, correspondingly, using the Graph Pad Prism version 5.01 software for Windows, oxygen species (ROS) production was evaluated in astrocytes exposed to 25, 50, 125, 250, 500 and 1000 nM MMA III through a previously reported method [25] . Astrocytes were cultured in a black walled 96-well plate, 8 × 10 3 cells/well were allowed to settle for 24 h before conducting the assays. The medium was removed from the wells and replaced with phenol red-free 10 % serum-supplemented DMEM; 100 μL of the different MMA III concentrations were added to the wells at two-times the final desired concentrations; the same volume of a 200 µM 2′7′dichlorodihydrofluorescein diacetate (DCF H-DA) solution was added to each well. Cells exposed to 10 μM sodium nitroprusside (SNP) were used as positive control. ROS production was evaluated as fluorescence intensity in a fluorospectrophotometer at 488-nm excitation and 525-nm emission wavelengths. Fluorescence intensity was measured every 5 min the first hour and at 2, 4, and 6 h after MMA III had been added to the culture.
Nitric Oxide (NO) Production Assay
Accumulation of nitrite as a result of the oxidation of produced NO was measured by the Griess reaction in MMA III -exposed astrocytes. Cells were seeded on 96-well, flat bottom, culture plates and incubated for 24 h. The medium was discarded and replaced with phenol red-free DMEM containing 2 % fetal bovine serum and 100 U/mL penicillin and 100 μg/mL streptomycin containing 0, 25, 50, 125, 250, 500 and 1000 nM MMA III . SNP 10 mM was included as a positive control for NO release. Astrocytes were allowed to grow for 24 additional hours in presence of the toxicant. After the incubation, 100 μL of the supernatant were mixed with the same volume of Griess reagent [0.1 % N-(1-naphthyl) ethylenediamine dihydrochloride in deionized water and 2 % sulfanilamide in 0.5 M HCl]. The absorption at 540 nm with a reference wavelength at 620 nm was recorded with a microplate reader (Multiskan, LabSystems, Beverly, MA, USA). Total nitrite concentration in samples was determined from a NaNO 2 standard curve.
Proliferation Assay
Proliferation assay was based on the measurement of 5-bromo-2-deoxyuridine (BrdU) incorporation during DNA synthesis through the use of a commercial ELISAbased system. The assay was conducted according to the provider's protocol (Cell proliferation ELISA BrdU, Roche, USA). Briefly, cells were incubated with the desired MMA III concentration for 24 and 48 h. BrdU labeling solution was added to the cultures at least 8 h before the ELISA assay was performed. The culture medium was removed, cells were fixed, and DNA was denatured. Afterwards, cells were incubated with anti-BrdU-POD solution for 90 min, and antibody conjugates were removed in three washing
Cytotoxicity Assays
To determine the toxic effects of different MMA III concentrations on astrocytes, cell viability and cell membrane integrity, as well as morphological changes, were evaluated.
At concentrations of 50-2500 nM (5 μM), MMA III did not lead to any cell toxicity signs on the rat cortical astrocytes after 24 h exposure in terms of morphological changes. However, at higher concentrations astrocytes started to lose their classical shape and became detached from plates when compared to non-treated cells. The most significant MMA III -mediated toxic effect was observed in cells treated with 15,000 nM of MMA III , which led cells to detach from the flask and they appeared severely damaged (Fig. 2) .
The effect of MMA III on membrane integrity after 24 h exposure was evaluated through LDH release. As shown in Fig. 3 As can be noticed in F ig. 3, in our hands, LDH activity from supernatants of astrocytes exposed to 25-1000 nM MMA III for 24 h showed a trend to decrease compared to non-exposed cells. It is important to point out that there is always some remnant LDH activity in the cell culture Graph Pad Software (San Diego, CA, USA). Data are presented as the mean (±SD) and p < 0.05 was considered significant.
Results
Cellular characterization through GF AP-immunostaining showed that cultures were composed of around 98 % astrocytes (Fig. 1) . Fig. 1 Astrocytes culture characterization. Primary rat cortical astrocytes cultures were characterized through immunostaining against glial fibrillary acidic protein (GFAP). After removing microglial cells from cultures through agitation, cell cultures were constituted by 95 % astrocytes. Green staining corresponds to anti-GF AP labeled astrocytes whereas blue staining corresponds to DAPI dye, which identifies the cellular nuclei LDH activity was measured to determine the effect of MMA III on this enzyme in astrocytic cultures. To do this, cells were incubated with 25-5000 nM MMA III for 24 or 48 h. Then, in one set of cells the culture medium was removed and cells were lysed after 24 or 48 h exposure with the buffer provided by the LDH kit's manufacturer and lysates were collected. In another set of cellular cultures, medium due to supplementation with 2 % SBF; therefore, even supernatants from healthy non-exposed cells show some background LDH activity. However, absorbance data obtained of supernatants from astrocytes exposed to nontoxic concentrations were consistently lower than control, suggesting that MMA III could be affecting LDH activity. Therefore, in a different set of experiments, intracellular 
Exposure to Low Nanomolar MMA III Concentrations Induced ROS Production
Oxidative stress is a quick response that is very often elicited after the cells are exposed to different toxic substances. In this work, cortical astrocytes were exposed to MMA III in concentrations ranging from 25 to 1000 nM and assayed for ROS production. Results showed that only those astrocyte cultures that were exposed to 25 and 50 nM MMA III had a strong oxidative response as soon as 3 min after the toxicant had been added to the cells. Based on the oxidation of DAFH-related fluorescence, it was calculated that around 70 % more ROS was produced after only 3 min in cells exposed to 50 nM MMA III when compared to non-exposed supernatants were recovered after 24 or 48 h exposure. LDH activity in supernatants and in cellular lysates was measured as described before. Cells without exposure to MMA III were included as control. In this case, results were presented as LDH activity as a function of the MMA III concentration to which the astrocytes had been exposed.
As seen before, supernatants from astrocytes exposed for 24 or 48 h to 50-1000 nM MMA III showed a decreased LDH activity, determined in terms of absorbance due to formazan formation, compared with non-exposed cells, mainly after 48 h exposure (F ig. 4a). On the other hand, intracellular LDH activity was significantly decreased (up to 70 %) in astrocytes treated with any of the MMA III assayed concentrations (Fig. 4b) .
One possible explanation for this observation is that at low non-cytotoxic MMA III concentrations, the LDH activity of the serum-containing medium is inhibited by the MMA III added to the medium where the cells were grown; however, higher MMA III concentrations are toxic for astrocytes inducing their lysis and, therefore, releasing a high LDH amount to the medium that can be detected in supernatants. However, for the intracellular LDH determination in astrocytes, after 24 or 48 h exposure to 50-5000 MMA III , the latter has III . b Decreased intracellular LDH activity. Astrocytes were exposed to 25, 50, 125, 250, 500, 1000, 2500 and 5000 nM MMA III for 24 or 48 h and then lysed. Released LDH activity was determined using the same LDH-based toxicity assay. Asterisks denote significant differences between not-treated and treated cells, p ≤ 0.05, n = 3 to 25-1000 nM MMA III were also assayed for proliferation induction after 24 and 48 h through the BrdU incorporation assay. Results showed that all assayed concentrations led the cortical astrocytes to incorporate more BrdU to DNA in presence of MMA III in a dose-response fashion. This result could be interpreted as increased cellular proliferation; however it could also be the result of an increased Asinduced damage/repair process as previously reported [26] . This effect was apparently independent from the oxidative intracellular state, but it seems to agree with the IL-6 overexpression found at all assessed MMA III concentrations (Fig. 6) .
Astrocytes Showed Increased Metabolic Activity After Exposure to MMA III
Astrocytes mainly rely on anaerobic oxidative phosphorylation to get energy, for this reason aerobic metabolism, which is mediated by mitochondria, is weaker in these cells when cells. ROS production duplicated after 55 min and peaked at 6 h post-exposure to 50 nM and at 24 h post-exposure to 25 nM. Interestingly, exposure to higher concentrations did not increase ROS as compared to untreated cells. Therefore, in our conditions, oxidative stress induction by MMA III did not follow a dose-dependent behavior (Fig. 5) .
On the other hand, we found no significant differences in NO production after exposure to MMA III when compared to non-treated cells (data not shown), suggesting that MMA III did not induce nitrosative stress in rat cortical astrocytes at the assayed MMA III concentrations.
Exposure to MMA III Increased BrdU Incorporation in Cortical Astrocytes
The intracellular oxidative stress, as well as inflammatory cytokines, is known to induce activation of several intracellular pathways including those related with cell survival and proliferation. Astrocytes that were exposed for 24 or 48 h with ROS over-expression, 50 nM MMA III induced the most significant changes in the expression of genes coding for IL-1β, IL-6, TNF-α, MIF, and COX-2; the COX-2 transcript was the one to show the biggest change at this MMA III concentration (up to 29.9 %). The same genes were found over-expressed in cells exposed to 125 nM MMA III although the changes were not as impressive as with 50 nM. Cells exposed to 500 nM MMA III showed an over-regulation of three pro-inflammatory genes, IL-1-β, IL-6, and TNF-α, whereas IL-6 was the only gene over-expressed in cells exposed to 125 and 1000 nM MMA III (Fig. 8 ). These results show that As-induced inflammatory response neither follows a dose-response behavior in rat cortical astrocytes; rather the most relevant changes seem to depend on the intracellular oxidative state.
MM III Induced APP and BACE-1 Gene Over-expression in Astrocytes
Reactive astrocytes are implicated in amyloid plaques formation due to the fact that inflammatory responses induce BACE-1 increased expression, leading to an increased APP processing through the amyloidogenic pathway [23] . Importantly, as is discussed later on, Aβ oligomers (AβOs) accumulation in the synaptic cleft induces memory and learning impairment [29] . Therefore, we examined the effect of acute exposure to MMA III on the expression of genes encoding for the APP, as well as of the gene encoding for BACE-1, which is implicated in Aβ formation. As shown in F ig. 9, APP gene expression showed a significant increase in astrocytes after exposure to 50, 125 and 500 nM MMA III , which was also consistent with an increased BACE-1 gene expression. These concentrations were shown to induce IL-1β, IL-6, and TNF-α over-regulation in astrocytes, suggesting that these cytokines could be associated to the observed increase in APP and BACE-1 expression.
compared to neurons that use glycolysis for ATP production. However under stressful conditions, astrocytes increase aerobic metabolism to overcome the energy need [27] . MMA III effect on astrocytes metabolism was assayed through the MTS transformation assay, which mainly evaluates aerobic mitochondrial activity. Reduction of MTS is mediated by NADH or NADPH inside and out of mitochondria [28] and this assay's results can be used to measure changes in cellular metabolism. Results show a significant increase of up to 28.3 % in the ability to reduce MTS in cells exposed to 25, 50, 125 and 250 nM MMA III when compared to nonexposed cells (Fig. 7) .
MMA III Increased Pro-inflammatory Cytokine Gene Expression in Astrocytes
We investigated whether MMA III is able to induce proinflammatory genes transcription in cortical astrocytes. Astrocytes were exposed for 6 h to sub-toxic concentrations of MMA III (50, 250 , 500 and 1000 nM). Consistent been described could be involved in the cognitive deficit that has been observed in children and adults exposed to As-contaminated water, as well as in experimental models, including: (a) impaired monoaminergic [30, 31] , glutamatergic [32] and cholinergic [33] signaling; (b) increased APP expression and B amyloid formation [34] , (c) impaired synaptic transmission [35] , increased tau protein phosphorylation [36, 37] , and reticulum endoplasmic stress induction [38] . All these As-induced neurotoxicity mechanisms are related directly or indirectly to inflammatory responses impairment [39] . In this regard, microglial cells have been extensively studied as the primary effectors of inflammatory responses in the CNS after a brain aggression; however, various reports have shown that astrocytes, the most abundant glial cells that contribute to the blood-brain barrier architecture and function, are the first cells to respond to a toxic challenge and induce microglia recruitment through different chemokines production [40, 41] . Impaired astrocytes' functioning has been associated with neurological disorders, such as Alzheimer and Parkinson disease [22, 42] . However, there is scarce information in the formal literature exploring the As-induced inflammatory response and its consequences on astrocytes.
As described by Koehler et al. [43] , astrocytes are able to reduce intracellularly arsenate to arsenite, to keep it in a reduced state and to metabolize it through methylation to form MMA and DMA. In Bergman cells, a special type of radial glial cells, MMA III is produced and accumulated up to 1.2 ng/mg protein after a single in vitro exposure to 1.5 μM iAs without compromising cells viability. In such glial cells, MMA III accounted for 60 % of total intracellular As, representing the main accumulated As species after 24 h exposure to arsenite [44] . Based on these observations and because MMA III has been demonstrated to impair a variety of cellular functions, including those related to proliferation, oxidative stress, and inflammation; in this work, rat cortical astrocytes were exposed in vitro to nanomolar concentrations of this metabolite to determine their effect on oxidative and inflammatory responses.
In our experimental conditions, LDH and MTS-based toxicity assays showed that rat cortical primary astrocytes were highly resistant to MMA III (LD 50 = 10.5 μM), which is consistent with previous studies showing that astrocytes are able to resist high arsenite concentrations; those studies show that astrocytes viability gets compromised at concentrations ranging from 200 to 1.0 mM after 24 h in vitro incubation with this toxicant [43, 45, 46] .
In this sense, it is relevant to point out that astrocytes play a critical role in iron and copper homeostasis, being able to introduce and accumulate these metal ions in high concentrations without compromising viability [47, 48] . It is possible that astrocytes are able to handle such high arsenic concentrations through these or similar mechanisms.
Discussion
iAs and its metabolites-related toxicity has been extensively studied elsewhere in vitro or through the use of different animal models. Specifically, some of the mechanisms that have These results suggest that MMA III induces activation of inflammatory and proliferative responses through a mechanism that seems to be independent of the intracellular oxidative state and without compromising astrocyte viability, but increasing cells proliferation and metabolism. However, oxidative stress seems to contribute to MMA III -induced pro-inflammatory responses in astrocytes exposed to low MMA III concentrations. Up to this point, we demonstrated that MMA III is able to induce astrocytes-mediated inflammatory cytokines over-expression, which correlates with increased cellular proliferation and metabolic activity. This pro-inflammatory environment, generated by MMA III in astrocytes, could contribute to the development of cognitive impairment in exposed populations.
It is important to remember that amyloid plaques, formed by insoluble protein fibrils, are associated with human cognitive decline and neurodegeneration. These fibrils are formed of Aβ derived from the proteolytic cleavage of the APP [57] , however soluble AβOs, which are not detected through regular tissue staining techniques, have been demonstrated to be the neurotoxic form of Aβ [29, 58] .
A pro-inflammatory environment is known to be the cause of BACE-1 over-regulation, leading to the formation of AβOs [59] . In mouse, the levels of APP are increased in pro-inflammatory conditions [60] . Moreover, Zhao et al. [23] , demonstrated that pro-inflammatory cytokine combinations, like TNF-α plus IFN-γ, synergistically increase levels of endogenous APP and BACE1 in astrocytes, as compared to individual cytokines alone. On the other hand, As is reported to affect expression and processing of APP in neuronal cells [34, 61] . Therefore, the connecting factor between arsenic-induced neurotoxicity and AβOs formation is very likely to be the As-induced inflammatory responses.
Importantly, several reports suggest that astrocytes are also able to produce and accumulate Aβ through the increase in BACE-1 expression [22, 23] , therefore contributing to neurodegeneration.
In agreement with this observation, our results showed an increased APP and BACE-1 gene expression mainly after astrocytes were exposed to 50, 125 and 500 nM MMA III , the same MMA III concentrations that showed a more significant induction of IL-1b, IL-6 and TNF-α gene expression, suggesting that these cytokines could play a critical role in astrocyte-mediated AB production.
It is well known that Inflammation plays a key role in the onset and progression of sporadic AD [14] . The mechanisms involve astrocytes and microglia activation, which over-express IL-1, promoting APP translation through an IL-responsive element located in the 5′-untranslated region (5′-UTR) of APP mRNA [62] .
Recently, Ashok [63] demonstrated that oxidative stress and inflammation induced by As, in rats exposed from Astrocytes are also known to play a critical role in the defense against oxidative stress and toxins since they express high glutathione concentrations and show elevated glutathione peroxidase and glutathione reductase activity. Additionally astrocytes express high concentrations of enzymes that supply the required NADPH for reduction reactions [49] . In the present work, astrocytes acutely exposed to 25 and 50 nM MMA III showed a strong oxidative response in the first few minutes after exposure, which remained high after 6 h for 50 nM MMA III and after 24 h for cells exposed to 25 nM MMA III , whereas higher concentrations failed to induce oxidative stress, even at micromolar concentrations. Previous works have demonstrated that after exposure to high micromolar arsenite concentrations (1.5-10 μM iAs) astrocytes do not show oxidative stress, due to the increased superoxide dismutase 1 (SOD 1) expression, however, with such iAs concentrations several intracellular pathways were impaired and DNA damage was observed [44, 50] . In this work, we cannot explain why only low MMA III (25 and 50 nM) concentrations induced cellular oxidative stress, and higher concentrations did not, but it is possible that the protective anti-oxidant mechanisms in cortical astrocytes are triggered only once a threshold of toxic levels of intracellular ROS production has been reached.
In the brain, after a trauma, astrocytes and other glial cells get activated and proliferate causing sustained inflammatory processes, which trigger the release of several neurotoxic molecules, such as ROS, nitric oxide, and more pro-inflammatory cytokines, such as IL-1, IL-6, TNF-α, IFN-γ. These molecules have been related to neuronal harm and are proposed to be involved in the generation or progression of neurodegenerative diseases, such as AD [19] . In this sense, it is well known that iAs and its methylated metabolites induce in vivo as well as in vitro inflammatory responses that, in turn, activate different signaling pathways associated with inflammation, proliferation, and cell survival [16, [51] [52] [53] [54] [55] [56] .
Our group has previously demonstrated that in vitro exposure to MMA III at concentrations as low as 50 nM leads to the activation of different signaling pathways and transcription factors associated with cell proliferation survival and inflammatory responses activation, including NFκβ, AP-1/c-Jun, ERK1/2, and AKT in a model of immortalized human urothelial cells [16] . Here, we demonstrated that different sub-toxic nanomolar concentrations of MMA III induce rat cortical astrocytes to over-regulate pro-inflammatory cytokines expression in a dose-response manner. Interestingly, bigger changes in IL-1β, IL-6, TNF-α, MIF, and COX-2 were observed in cells exposed to low MMA III concentrations (50 nM), the same concentration that previously showed to induce oxidative stress in treated astrocytes in this study, whereas higher concentrations led to less impressive changes.
compromise neurons' energetic metabolism through the activation of astrocytic inflammatory responses.
As a whole, observations of this exploratory study suggest that As could lead to memory impairment and possibly to neurodegeneration through the activation of oxidative and inflammatory responses, which in turn increase Aβ formation through APP and BACE-1 over-regulation in astrocytes. These results also suggest that exposure to arsenic may induce important metabolic and functional changes in astrocytes that have a negative impact on brain homeostasis. In summary, we consider these results as relevant general evidence on the role of astrocytes in the pathogenicity of cognitive impairment and neurodegeneration in As-exposed populations; further studies should be done in this direction.
05 days of gestation and up to 180 days postnatal, lead to an enhanced APP expression that is further processed by the enzymes BACE1 and presenilin (PS), leading to an Aβ over-production. Furthermore, at 90 days post-natal exposure, animals showed a significant cognitive impairment. IL1-β over-regulation was found in association with increased APP protein expression in these animals. Authors demonstrated that the corresponding mechanism involved the interleukin-responsive region located at the 5′-untranslated region (5′-UTR) of APP mRNA previously described [62] .
Based on our results and former observations, we hypothesize that MMA III , which is produced and accumulated by astrocytes, induces APP increased gene expression as a result of increased IL-1b, IL-6, and TNF-α gene expression. In turn, IL-1β binds to APP mRNA positively modulating its translation in ribosomes. On the other hand, MMA III -induced BACE-1 over expression increases APP processing towards the amyloidogenic pathway leading to AβOs formation.
One of the mechanisms that has been described through which Aβ contributes to cognitive impairment and neurodegeneration involves neuronal ionotropic receptors, AMPAand NMDA-type, and the metabotropic glutamate receptor, mGluR5, implicated in memory formation, which are targeted by AβOs. Accordingly, increased AβOs levels or the injection of AβOs in rodent's brains are known to impair synaptic plasticity by inhibiting long term potentiation (LTP) [29] .
On the other hand, as described in the "Results" section, concentrations ranging from 25 to 5000 nM MMA III led to a significant decrease in intracellular LDH activity, which was measured through the conversion of lactate to pyruvate based on the LDH activity determination commercial system. As known, astrocytes provide neurons with lactate that is used as their main ATP source by them and is essential for long term memory formation (LTM) [27] . Therefore, LDH inhibition may impair the lactate shuttle between astrocytes and neurons, compromising neuronal energy metabolism and having effect on LTM. We consider this a very interesting topic that needs further investigation.
Another interesting finding of the present study was the significant increased aerobic metabolic activity of astrocytes after exposure to 25, 50, 125 and 250 nM MMA III , which seems to be consistent with the most important changes observed in pro-inflammatory genes expression. In this sense, it has been proposed that inflammatory responses and increased mitochondrial aerobic metabolism are interconnected in astrocytes. It has been found that the inflammatory cytokines IL-1 and TNF-α stimulate astrocytic oxidative mitochondrial metabolism, leading to a decreased lactate supply to neurons [64] . In this way, arsenic may also
